On July 1, I had the honour to lead the singing of “O Canada” at the Lieutenant Governor’s Garden Party at Government House in celebration of Canada Day. And here’s a video! Here I am …
My young-YA/middle-grade fantasy Fireboy, already a finalist for Best Young Adult Novel in this year’s Aurora Awards and finalist for a 2027 Manitoba Young Readers’ Choice Award in the Northern Lights Division, has just been …
Had a great time being part of the cast of Regina Lyric Musical Theatre‘s production of Sweeney Todd: The Demon Barber of Fleet Street. I played Fogg (the insane asylum keeper) and also sang in …
My young-YA/middle-grade fantasy Fireboy, a nominee for Best Young Adult Novel in this year’s Aurora Awards, is also a finalist for the 2027 Manitoba Young Readers’ Choice Award in the Northern Lights Division. This is …
I’m thrilled to announce that I’m up for two Aurora Awards this year! Fireboy is on the ballot for Best Young Adult Novel, and The Worldshapers is once again on the ballot for Best Fan …
I spent a good chunk of today at Wordbridge, the annual writers’ conference in Lethbridge, Alberta. My main reason for coming was to launch a Shadowpaw Press title (Broken Realm by Jenna Greene, a Lethbridge …
Previous
Next
Major breakthrough in the treatment of cancers and infectious diseases
That’s what the headline on this press release says. A team led by Dr. André Veillette, a researcher at the Institut de recherches cliniques de Montréal, has identified a molecule, EAT-2, that suppresses the killer function of NK (“natural killer”) cells, which are central to the immune system. If medication that inhibits EAT-2 can be developed, NK cells can be much more effective at killing germs and cancer cells.
And, in fact, Dr. Veillette’s team has shown exactly that in mice in which the EAT-2 protein has been eliminated through genetic engineering: the NK cells produced by the mice are much more ffective at killing cancer cells.
Sounds promising!
Permanent link to this article: https://edwardwillett.com/2005/08/major-breakthrough-in-the-treatment-of-cancers-and-infectious-diseases/
